v3.26.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2024
Revenues $ 299,155 $ 222,818 $ 145,639
Cost of revenues 207,776 160,964 110,356
Gross profit 91,379 61,854 35,283
Operating expenses:      
Research and development 15,744 11,425 7,991
Selling, general and administrative 57,647 43,091 31,600
Amortization of acquisition related intangibles 2,371 1,733 2,152
Change in fair value 4,171 6,682 4,922
Restructuring 0 0 (14)
Total operating expenses 79,934 62,931 46,651
Operating income (loss) [1] 11,445 (1,077) (11,368)
Interest income, net 6,356 3,708 1,302
Other expense, net (1,053) (265) (736)
Income (loss) before income tax (benefit) expense 16,748 2,366 (10,802)
Income tax (benefit) expense (117,061) (3,667) 309
Net income (loss) $ 133,809 $ 6,033 $ (11,111)
Net income (loss) per common share      
Basic (in dollars per share) $ 3.12 $ 0.16 $ (0.37)
Diluted (in dollars per share) $ 3.05 $ 0.16 $ (0.37)
Weighted average number of common shares outstanding      
Basic (in shares) 42,945 36,990 29,825
Diluted (in shares) 43,902 37,718 29,825
[1] The significant expense categories and amounts align with the segment-level information that is regularly provided to the chief operating decision maker.